Ebos GroupASX:EBO +0.30%77 OCF Yield % is 6.97 as of Jun. 28, 2026, which is 29% above its 10-year median of 5.42. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$32.52 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 117 Medical Distribution companies, Ebos Group ranks better than 54.7% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ebos Group OCF Yield % Related Terms
Ebos Group OCF Yield % Historical Data
* Premium members only.
The historical data trend for Ebos Group's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group OCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Ebos Group's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a OCF Yield % of 6.97 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ebos Group and its competitors. This is 29% above median its historical median of 5.42. Over the past decade, Ebos Group's OCF Yield % has ranged from 3.21 to 11.70. According to the industry distribution chart, Ebos Group ranks #53 out of 117 companies in the Medical Distribution industry, placing it in the top 45.3%.
Is Ebos Group's OCF Yield % too high?
Ebos Group's current OCF Yield % of 6.97 is 29% above median its 10-year median of 5.42. Over the past 10 years, this metric has ranged from a low of 3.21 to a high of 11.70. The Medical Distribution industry median OCF Yield % is 5.97. Ebos Group's value of 6.97 is 16.8% above this industry median. Based on the distribution chart, Ebos Group ranks #53 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's OCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #53 out of 117 companies for OCF Yield %. This puts Ebos Group in the upper half of its industry. The industry median OCF Yield % is 5.97. Ebos Group's value of 6.97 is 16.8% above this benchmark. Historically, Ebos Group's own OCF Yield % has ranged from 3.21 to 11.70 over the past decade. While the company's 10-year median is 5.42 vs. the industry median of 5.97, Ebos Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Distribution company?
The median OCF Yield % among Medical Distribution companies is 5.97, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current OCF Yield % of 6.97 is 16.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median OCF Yield % is 5.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current OCF Yield % is 6.97, which is 29% above median its own 10-year median of 5.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$32.52, compared to a current price of A$16.76 — trading 48.5% below its estimated fair value. The current OCF Yield % is 6.97, which is 29% above median its 10-year median of 5.42 and 16.8% above the Medical Distribution industry median of 5.97. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current OCF Yield % is 6.97 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$16.76 is trading 48.5% below its estimated GF Value™ of A$32.52.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
OCF Yield %: 6.97 (29% above median its 10-year median of 5.42)
GF Value™: A$32.52 vs. price of A$16.76 (48.5% below fair value)
Industry Position: 16.8% above the Medical Distribution median (#53 of 117)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
